UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
EndowmentPosition in CELC — Celcuity Inc.
CIK 1019231
AUSTIN, TX
Position in CELC
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$283,101
New position
Shares Held
2,706
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#197
of 273 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO holds $14,630,603 across 16 Biotechnology names. CELC ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMTX |
Immatics N.V.
|
697,431 | $7,064,976 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
32,838 | $2,445,774 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
33,065 | $1,891,979 | |
| 4 | ANRO |
Alto Neuroscience, Inc.
|
22,175 | $585,198 | |
| 5 | RNTX |
Rein Therapeutics, Inc.
|
511,610 | $532,074 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
1,525 | $510,554 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
7,488 | $289,785 | |
| 8 | CELC |
Celcuity Inc.
This page
|
2,706 | $283,101 |
All Filings in CELC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $283,101 | 2,706 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||